Skip to main content
SpringerLink
Log in

Localized bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitor treatment

  • Correspondence
  • Published:
European Journal of Dermatology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bene J, Moulis G, Bennani I, et al. Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French Pharmacovigilance Database. Br J Dermatol 2016; 175: 296–301.

    Article  PubMed  CAS  Google Scholar 

  2. Person JR, Rogers RS 3rd JR, Perry HO. Localized pemphigoid. Br J Dermatol 1976; 95: 531–4.

    Article  PubMed  CAS  Google Scholar 

  3. Mehta V, Balachandran C. Localized flexural bullous pemphigoid. Indian J Dermatol 2008; 53: 157–8.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Zhao Y, Yang L, Wang X, Zhou Z. The new insights from DPP-4 inhibitors: their potential immune modulatory function in autoimmune diabetes. Diabetes Metab Res Rev 2014; 30: 646–53.

    Article  PubMed  CAS  Google Scholar 

  5. Stavropoulos PG, Soura E, Antoniou C. Drug-induced pemphigoid: a review of the literature. J Eur Acad Dermatol Venereol 2014; 28: 1133–40.

    Article  PubMed  CAS  Google Scholar 

  6. Garcia M, Aranburu MA, Palacios-Zabalza I, Lertxundi U, Aguirre C. Dipeptidyl peptidase-IV inhibitors induced bullous pemphigoid: a case report and analysis of cases reported in the European pharmacovigilance database. J Clin Pharm Ther 2016; 41: 368–70.

    Article  PubMed  CAS  Google Scholar 

  7. Attaway A, Mersfelder TL, Vaishnav S, Baker JK. Bullous pemphigoid associated with dipeptidyl peptidase IV inhibitors. A case report and review of literature. J Dermatol Case Rep 2014; 8: 24–8.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Bene J, Jacobsoone A, Coupe P, et al. Bullous pemphigoid induced by vildagliptin: a report of three cases. FCP 2015; 29: 112–4.

    PubMed  CAS  Google Scholar 

  9. Izumi K, Nishie W, Mai Y, et al. Autoantibody profile differentiates between inflammatory and noninflammatory bullous pemphigoid. J Invest Dermatol 2016; 136: 2201–10.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Dermatology, Mito Kyodo General Hospital, Sapporo, Japan

    Kazumasa Oya & Shijima Taguchi

  2. Department of Diabetes and Endocrinology, Mito Kyodo General Hospital, Sapporo, Japan

    Masanao Fujii

  3. Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan

    Wataru Nishie, Kentaro Izumi & Hiroshi Shimizu

Authors
  1. Kazumasa Oya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masanao Fujii
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shijima Taguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wataru Nishie
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kentaro Izumi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hiroshi Shimizu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kazumasa Oya.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Oya, K., Fujii, M., Taguchi, S. et al. Localized bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitor treatment. Eur J Dermatol 28, 250–251 (2018). https://doi.org/10.1684/ejd.2018.3230

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2018.3230

Search

Navigation